Could a balloon pump before angioplasty save more hearts?

NCT ID NCT07761455

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This trial tests whether starting a temporary balloon pump in the aorta before the standard artery-opening procedure (angioplasty) can improve outcomes for people who arrive at the hospital 4 to 12 hours after a major heart attack. Half of the participants will receive the balloon pump plus standard angioplasty, while the other half will receive angioplasty alone. The study tracks deaths, heart failure, and cardiogenic shock over 180 days to see if the extra support helps.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Intra-aortic balloon pump (IABP) started before standard angioplasty
What this could lead to
If effective, this approach could reduce deaths, heart failure, and shock in people who arrive late after a major heart attack.
What could go wrong
The trial is still testing the idea, and the balloon pump carries risks like bleeding or vascular injury. Results may not apply to all heart attack patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ANTERIOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fuwai Hospital, Chinese Academy of Medical Sciences

    Beijing, 100037, China

  • Jining No.1 People's Hospital

    Jining, Shandong, 272011, China

  • Qilu Hospital of Shandong University, Jinan, Shandong, China

    Jinan, Shandong, 250012, China

  • The Affiliated Hospital of Qingdao University

    Qingdao, Shandong, 266003, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.